Yuran Zhu

Yuran Zhu

Auto-generated profile, based on publicly available information

Yuran Zhu

Department of Biomedical Engineering Case Western Reserve University Cleveland Ohio USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2024 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
YZYuran Zhu
Yuran Zhu
GWGuanhua Wang
Guanhua Wang
YGYuning Gu
Yuning Gu
WZWalter Zhao
Walter Zhao
JLJiahao Lu
Jiahao Lu
XYXin Yu
Xin Yu
Purpose: Quantitative MRI enables direct quantification of contrast agent concentrations in contrast‐enhanced scans. However, the lengthy scan times required by conventional methods are inadequate for tracking contrast agent transport dynamically in mouse brain. We developed a 3D MR fingerprinting (MRF) method for simultaneous T1 and T2 mapping across the whole mouse brain with 4.3‐min temporal resolution.Method: We designed a 3D MRF sequence with variable acquisition segment lengths and magnetization preparations on a 9.4T preclinical MRI scanner. Model‐based reconstruction approaches were employed to improve the accuracy and speed of MRF acquisition. The method's accuracy for T1 and T2 measurements was validated in vitro, while its repeatability of T1 and T2 measurements was evaluated in vivo (n = 3). The utility of the 3D MRF sequence for dynamic tracking of intracisternally infused gadolinium‐diethylenetriamine pentaacetic acid (Gd‐DTPA) in the whole mouse brain was demonstrated (n = 5).Results: Phantom studies confirmed accurate T1 and T2 measurements by 3D MRF with an undersampling factor of up to 48. Dynamic contrast‐enhanced MRF scans achieved a spatial resolution of 192 × 192 × 500 μm3 and a temporal resolution of 4.3 min, allowing for the analysis and comparison of dynamic changes in concentration and transport kinetics of intracisternally infused Gd‐DTPA across brain regions. The sequence also enabled highly repeatable, high‐resolution T1 and T2 mapping of the whole mouse brain (192 × 192 × 250 μm3) in 30 min.Conclusion: We present the first dynamic and multi‐parametric approach for quantitatively tracking contrast agent transport in the mouse brain using 3D MRF.

13 August 2025 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
CMChristina J. MacAskill
Christina J. MacAskill
YZYuran Zhu
Yuran Zhu
GWGuanhua Wang
Guanhua Wang
BEBernadette O. Erokwu
Bernadette O. Erokwu
CDChetan B. Dhakan
Chetan B. Dhakan
CFChris A. Flask
Chris A. Flask
Purpose: The clinical utility of conventional DCE‐MRI methods is limited by the use of conventional qualitative dynamic T1‐weighted images, resulting in poor reproducibility. This study presents the initial implementation of a new DCE‐magnetic resonance fingerprinting (DCE‐MRF) methodology to provide reproducible, quantitative assessments of tumor vascular perfusion.Methods: The DCE‐MRF acquisition combines multiple T1 preparations, highly undersampled spiral trajectories (R = 48), a low‐rank reconstruction method, and low tip angles on a 9.4 T preclinical MRI scanner to rapidly generate dynamic T1 maps (23‐s temporal resolution). In vitro validation experiments were conducted across a range of Gadovist concentrations to assess accuracy and temporal precision in comparison to conventional methods. The DCE‐MRF method was also evaluated in vivo in an orthotopic 4T1 mouse model of breast cancer (n = 25). Pharmacokinetic modeling of the in vivo data was performed using a linear reference region model (LRRM).Results: In vitro DCE‐MRF studies demonstrated good agreement with conventional MRI methods for T1 measurements (R2 0.99). The iterative low‐rank reconstruction method also reduced artifacts compared to conventional reconstruction methods. DCE‐MRF demonstrated a 2‐ to 3‐fold reduction in temporal variability compared to conventional DCE‐MRI, and enabled effective in vivo pharmacokinetic modeling using the LRRM by generating voxelwise maps of RKtrans and kep,T as measures of tumor vascular perfusion.Conclusions: DCE‐MRF represents a new inherently quantitative approach to measuring tumor vascular perfusion that can be used in animal models and eventually in patients.

24 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
YZYuran Zhu
Yuran Zhu
JZJunqing Zhu
Junqing Zhu
CNChenxin Ni
Chenxin Ni
ACAnbang Chen
Anbang Chen
LLLongshun Li
Longshun Li
XYXin Yu
Xin Yu
Tracer imaging has been instrumental in mapping the brain’s solute transport pathways facilitated by cerebrospinal fluid (CSF) flow. However, the impact of tracer infusion parameters on CSF flow remains incompletely understood. This study evaluated the influence of infusion location, rate, and anesthetic regimens on tracer transport using dynamic contrast-enhanced MRI with Gd-DTPA as a CSF tracer. Infusion rate effects were assessed by administering Gd-DTPA into the cisterna magna (ICM) at two rates under isoflurane anesthesia. Anesthetic effects were evaluated by comparing transport patterns between isoflurane and ketamine/xylazine (K/X) anesthesia at the slower rate. Gd-DTPA transport was also examined after lateral ventricle (ICV) infusion, the primary site of CSF production. The results demonstrate that, besides anesthesia, both the location and rate of infusion substantially affected solute transport within the brain. ICV infusion led to rapid, extensive transport into deep brain regions, while slower ICM infusion resulted in more pronounced transport to dorsal brain regions. Cross-correlation and hierarchical clustering analyses of region-specific Gd-DTPA signal time courses revealed that ICM infusion facilitated transport along periarterial spaces, while ICV infusion favored transport across the ventricular-parenchymal interface. These findings underscore the importance of experimental conditions in influencing tracer kinetics and spatial distribution in the brain.

1 February 2026 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
CMChristina J. MacAskill
Christina J. MacAskill
BEBernadette O. Erokwu
Bernadette O. Erokwu
YZYuran Zhu
Yuran Zhu
GWGuanhua Wang
Guanhua Wang
ADAndrew Dupuis
Andrew Dupuis
CFChris A. Flask
Chris A. Flask
Purpose: Dynamic contrast‐enhanced MRI (DCE‐MRI) can assess tumor perfusion using pharmacokinetic models. However, poor DCE‐MRI reproducibility from reliance on conventional T 1 ‐weighted MRI has limited clinical translation. We evaluated whether Dynamic Contrast Enhanced‐Magnetic Resonance Fingerprinting (DCE‐MRF), which directly generates quantitative T 1 relaxation time constant maps, provides improved precision and statistical power for detecting treatment‐induced vascular changes compared to conventional DCE‐MRI. Methods: Twenty female mice bearing orthotopic 4 T1 breast tumors were randomly assigned to DCE‐MRF ( n = 12) or conventional DCE‐MRI ( n = 8) cohorts. Both methods acquired matched spatial and temporal resolution (23‐s) T 1 measurements at baseline, 3 h, and 48 h post‐treatment with combretastatin A4 phosphate (120 mg/kg), a known vascular disrupting agent. Perfusion assessments were obtained with a pharmacokinetic Linear Reference Region Model ( RK trans and k ep,T ) and model‐independent initial area under the curve assessments and compared using Wilcoxon signed‐rank tests and Hedges' g effect sizes. Results: DCE‐MRF demonstrated 1.3‐to‐5.1‐fold larger effect sizes for RK trans across all regions and timepoint comparisons, and 1.3‐to‐1.9‐fold larger effect sizes for tumor rim k ep,T compared to conventional DCE‐MRI. RK trans and k ep,T at 3 h post‐treatment in all regions, detected significant vascular recovery for whole tumor RK trans and both whole tuomor and tumor rim for k ep,T at 48 h, whereas DCE‐MRI only detected significant changes at 3 h. Conclusions: DCE‐MRF's improved measurement precision and increased effect size translates directly to enhanced statistical power for detecting treatment‐induced vascular changes, positioning it as a more reproducible tumor perfusion assessment for animal models and eventually cancer patients.

4 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
YZYuran Zhu
Yuran Zhu
GWGuanhua Wang
Guanhua Wang
CKChaitanya Kolluru
Chaitanya Kolluru
YGYuning Gu
Yuning Gu
HGHuiyun Gao
Huiyun Gao
XYXin Yu
Xin Yu
Recent studies have suggested the glymphatic system as a key mechanism of waste removal in the brain. Dynamic contrast-enhanced MRI (DCE-MRI) using intracisternally administered contrast agents is a promising tool for assessing glymphatic function in the whole brain. In this study, we evaluated the transport kinetics and distribution of three MRI contrast agents with vastly different molecular sizes in mice. Our results demonstrate that oxygen-17 enriched water (H 2 17 O), which has direct access to parenchymal tissues via aquaporin-4 water channels, exhibited significantly faster and more extensive transport compared to the two gadolinium-based contrast agents (Gd-DTPA and GadoSpin). Time-lagged correlation and clustering analyses also revealed different transport pathways for Gd-DTPA and H 2 17 O. Furthermore, there were significant differences in transport kinetics of the three contrast agents to the lateral ventricles, reflecting the differences in forces that drive solute transport in the brain. These findings suggest the size-dependent transport pathways and kinetics of intracisternal contrast agents and the potential of DCE-MRI for assessing multiple aspects of solute transport in the glymphatic system.